Capricor Therapeutics
CAPR
#7368
Rank
NZ$1.00 B
Marketcap
NZ$17.25
Share price
-6.93%
Change (1 day)
75.04%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2026 (TTM): -NZ$0.23 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.2 Billion a decrease over its 2024 earnings that were of -NZ$73.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.23 Billion18.47%
2025 -NZ$0.2 Billion159.57%
2024 -NZ$73.25 Million81.57%
2023 -NZ$40.34 Million-23.2%
2022 -NZ$52.53 Million44.93%
2021 -NZ$36.24 Million46.61%
2020 -NZ$24.72 Million78.71%
2019 -NZ$13.84 Million-49.7%
2018 -NZ$27.5 Million-724.78%
2017 NZ$4.4 M-112.93%
2016 -NZ$34.04 Million46.27%
2015 -NZ$23.28 Million106.82%
2014 -NZ$11.26 Million-48.41%
2013 -NZ$21.81 Million977.23%
2012 -NZ$2.03 Million-77.11%
2011 -NZ$8.85 Million-22.35%
2010 -NZ$11.4 Million-20.17%
2009 -NZ$14.27 Million-41.17%
2008 -NZ$24.26 Million41.05%
2007 -NZ$17.2 Million1098.87%
2006 -NZ$1.44 Million4101.55%
2005 -NZ$0.04 Million-0.97%
2004 -NZ$0.04 Million17.87%
2003 -NZ$0.03 Million3.66%
2002 -NZ$0.03 Million-30.11%
2001 -NZ$0.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$33.88 B-14,566.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.56 B-766.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-NZ$1.41 Billion 501.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.59 Billion 151.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-NZ$15.16 Million-93.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$29.9 Million-87.23%๐Ÿ‡บ๐Ÿ‡ธ USA